QNRX

Quoin Pharmaceuticals
$4.29
+$0.01 (+0.23%)Jul 27, 2026
0.6PoorMoatMint rating

MoatMint rates Quoin Pharmaceuticals (QNRX) 0.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.3 out of 10.

Key metrics

The numbers that frame QNRX today
Market cap
$15.08M
P/E (TTM)
-0.9
EV / FCF
-0.8
ROIC
-369.4%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.25
52wk High
$41.80

QNRX stock rating

How QNRX scores on quality, value, growth, momentum and financial health
0.6out of 10
Low overallNeutral business, expensive priceTop 94% of ~5,000 US stocks
QualityPoor0.3/10
GrowthGreat9.7/10
MomentumPoor0.9/10
ValuePoor0.3/10
Financial HealthPoor1.0/10

Growth

Revenue and earnings trend for QNRX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about QNRX
Is Quoin Pharmaceuticals a good buy?
No. Quoin Pharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Quoin Pharmaceuticals is selling at a very high price.
What is the market capitalization of QNRX?
Quoin Pharmaceuticals's market capitalization is $15.08M.
What is the P/E ratio for QNRX stock?
Quoin Pharmaceuticals's current P/E ratio is -0.9.
What is the 52-week high for QNRX stock?
The 52-week high for Quoin Pharmaceuticals is $41.80. The current close of $4.29 is 89.7% below that high.
What is the 52-week low for QNRX stock?
The 52-week low for Quoin Pharmaceuticals is $3.25. The current close of $4.29 is 32% above that low.
Does QNRX stock pay dividends?
Quoin Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for QNRX?
Quoin Pharmaceuticals's Debt / Equity ratio is 0.